Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest in Chinese patients with endometriosis
NCT01822080Phase 3Completed
- Sponsor
- Bayer
- Start
- Mar 2013
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dienogest in endometriosis, sponsored by Bayer. Started Mar 2013; status: completed.
02
Drugs
dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT01822080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01822080.